{
    "clinical_study": {
        "@rank": "46968", 
        "arm_group": [
            {
                "arm_group_label": "Adalimumab", 
                "arm_group_type": "Experimental", 
                "description": "single administration of Adalimumab 80mg diluted in 5ml saline"
            }, 
            {
                "arm_group_label": "saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "5 ml of saline"
            }
        ], 
        "brief_summary": {
            "textblock": "We study if the administration of intralesional Adalimumab (directly  injected in the\n      stricture) associated to endoscopic dilatation has a higher success rate at week 8 compared\n      with placebo in patients with  Crohn's disease who had confirmed intestinal stenosis (3\n      stenosis as maximum)"
        }, 
        "brief_title": "Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Crohn's Disease", 
        "condition_browse": {
            "mesh_term": [
                "Crohn Disease", 
                "Intestinal Obstruction", 
                "Constriction, Pathologic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients of both sexes older than 18 years\n\n          -  Patient diagnosed of CROHN\u00b4s disease\n\n          -  Patient with intestinal stenosis length equal or less than 5cm previously confirmed\n             with bowel magnetic resonance imaging (3 stenosis as maximum)\n\n          -  Stenosis no permeable for endoscopy(12mm in case of accessible stenosis with\n             conventional colonoscopy and 10mm in case of accessible stenosis with balloon\n             enteroscopy)\n\n          -  Dilated stenosis according to endoscopist criteria (pass or no the endoscopy)\n\n          -  Patient capable of participate in the examinations required by the study\n\n          -  Patient after being informed, give his/her informed consent in writing\n\n        Exclusion Criteria:\n\n          -  Patients with large intestinal stenosis (more than 6cm) and multiples\n\n          -  Patients with previous or actual treatment with anti-tumor necrosis factor (anti-TNF)\n             drugs\n\n          -  Patients with positive serology to hepatitis B virus(HBV),hepatitis C virus (HCV), or\n             HIV\n\n          -  Patients with positive screening to Tuberculosis(positive PPD)\n\n          -  Established contraindication to anti-TNF drugs\n\n          -  Existence of fistulous tracts associated with intestinal stenosis\n\n          -  Neoplastic process associated with stenosis or in another location\n\n          -  Pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01986127", 
            "org_study_id": "CSAI", 
            "secondary_id": "2012-001723-12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Adalimumab", 
                "description": "single intralesional administration during endoscopy process", 
                "intervention_name": "Adalimumab", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "saline", 
                "description": "single intralesional administration during endoscopy", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Adalimumab"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Crohn disease", 
        "lastchanged_date": "February 18, 2014", 
        "location": [
            {
                "contact": {
                    "email": "ana.echarri.piudo@sergas.es", 
                    "last_name": "Ana Echarri, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ferrol", 
                        "country": "Spain", 
                        "state": "A Coru\u00f1a", 
                        "zip": "15405"
                    }, 
                    "name": "Complexo Hospitalario Arquitecto Marcide -Novoa Santos"
                }, 
                "investigator": {
                    "last_name": "Ana Echarri, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ebrullet@tauli.cat", 
                    "last_name": "Enric Brullet, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08208"
                    }, 
                    "name": "Hospital Parc Taul\u00ed"
                }, 
                "investigator": {
                    "last_name": "Enric Brullet, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "alfredo.matabilbao@sanitatintegral.org", 
                    "last_name": "Alfredo Mata, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sant Joan Desp\u00ed", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08970"
                    }, 
                    "name": "Hospital Moises Broggi"
                }, 
                "investigator": {
                    "last_name": "Alfredo Mata, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lmarquez@hospitaldelmar.cat", 
                    "last_name": "Lucia Marquez, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital del Mar"
                }, 
                "investigator": {
                    "last_name": "Lucia Marquez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "BGONZALS@clinic.ub.es", 
                    "last_name": "Bego\u00f1a Gonzalez Suarez, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic of Barcelona"
                }, 
                "investigator": {
                    "last_name": "Bego\u00f1a Gonzalez Suarez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "chuertas.girona.ics@gencat.cat", 
                    "last_name": "Carlos Huertas, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Girona", 
                        "country": "Spain", 
                        "zip": "17007"
                    }, 
                    "name": "Hospital Josep Trueta"
                }, 
                "investigator": {
                    "last_name": "Carlos Huertas, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cgasanza@yahoo.es", 
                    "last_name": "Cecilia Gonz\u00e1lez, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "Hospital G.U. Gregorio Mara\u00f1\u00f3n"
                }, 
                "investigator": {
                    "last_name": "Cecilia Gonzalez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "arguello_lid@gva.es", 
                    "last_name": "Lidia Arg\u00fcello, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46026"
                    }, 
                    "name": "Hospital La Fe"
                }, 
                "investigator": {
                    "last_name": "Lidia Arg\u00fcello, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-blinded, Placebo-controlled Study on the Effects of Adalimumab Intralesional Intestinal Strictures of Crohn's Disease Patients", 
        "overall_contact": {
            "email": "BGONZALS@CLINIC.UB.ES", 
            "last_name": "Bego\u00f1a Gonzalez Suarez, MD"
        }, 
        "overall_contact_backup": {
            "email": "svarea@clinic.ub.es", 
            "last_name": "Sara Varea Latorre, BSc"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Clinic of Barcelona", 
                "last_name": "Bego\u00f1a Gonz\u00e1lez Suarez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital del Mar", 
                "last_name": "Luc\u00eda M\u00e1rquez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Mois\u00e9s Broggi", 
                "last_name": "Alfredo Mata, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Josep Trueta", 
                "last_name": "Carlos Huertas, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital La Fe", 
                "last_name": "Lidia Arg\u00fcello, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Parc Taul\u00ed", 
                "last_name": "Enric Brullet, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Gregorio Mara\u00f1\u00f3n", 
                "last_name": "Cecilia Gonz\u00e1lez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Complexo Hospitalario Arquitecto Marcide-Novoa Santos", 
                "last_name": "Ana Echarri, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Successful dilatation means the passage of the endoscope (or enteroscopy colonoscope) through the stenosis", 
            "measure": "Success of endoscopic dilatation", 
            "safety_issue": "No", 
            "time_frame": "at week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01986127"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fundaci\u00f3 Cl\u00ednic per la Recerca Biom\u00e8dica", 
            "investigator_full_name": "Sara Varea", 
            "investigator_title": "Clinical Research Manager", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The endoscopic stenosis diameter will be estimated pre and post-dilatation", 
                "measure": "Stenosis measure", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "description": "The success of endoscopic dilatation at week 52 means absence of clinical subocclusion, no necessity of surgical nor endoscopic dilatation", 
                "measure": "success of endoscopic dilatation", 
                "safety_issue": "No", 
                "time_frame": "at week 52"
            }, 
            {
                "description": "Anastomotic strictures: We define mucosal healing as a Rutgeerts < or equal 2 with at least 1 point of improvement (a\u00f1adir el score)\nPrimary strictures: Absence of ulcers after treatment", 
                "measure": "Mucosal healing", 
                "safety_issue": "No", 
                "time_frame": "at week 8"
            }, 
            {
                "description": "We consider histological cure if:\nEpithelial damage is < or equal 1\nArchitectural changes is < or equal 1\nInfiltration of mononuclear cells in lamina propria is < or equal 1\nPolymorphonuclear cells in the lamina propria = 0\nPolymorphonuclear cells in epithelium = 0\nAbsence of erosions and ulcers (based ib scoring system for Histologic Abnormalities in Crohn's disease Mucosal Biopsy Specimens - Title: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Author(s): D'Haens, Geert R.; Geboes, Karel; Peeters, Mark; et al. Source: Gastroenterology  Volume: 114   Issue: 2   Pages: 262-267   Published: Feb., 1998)", 
                "measure": "Histological cure", 
                "safety_issue": "No", 
                "time_frame": "at week 8"
            }, 
            {
                "measure": "proportion of patients that develop anti-adalimumab antibodies", 
                "safety_issue": "No", 
                "time_frame": "at the end of the study"
            }, 
            {
                "measure": "adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "at the end of the study"
            }
        ], 
        "source": "Fundacion Clinic per a la Recerca Biom\u00e9dica", 
        "sponsors": {
            "collaborator": {
                "agency": "Hospital Clinic of Barcelona", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Sara Varea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}